With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.351498-10-7,6,6′-((1E,1’E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2,4-di-tert-butylphenol),as a common compound, the synthetic route is as follows.
In a nitrogen atmosphere, add to the reactor,2,2 ‘-[(1,1,2,2-tetramethyl-1,2-ethylenediyl) bis (nitromethyl)] bis [4,6-bis (1,1-dimethyl (Ethyl)] phenol, 16.46g (30mmol),21.6 g (152 mmol) of boron trifluoride-ether complex,300ml toluene20 g (152 mmol) of N, N-diisopropylethylamine was stirred with heating at 40 C for 2.5 hours.Cool to room temperature, add 300ml of water, and separate the filtrate into organic and aqueous layers.The organic layer was washed twice with a saturated sodium carbonate aqueous solution and dried over magnesium sulfate.The obtained solid was recrystallized from toluene (150 ml) and ethanol (750 ml),This gave 18.78 g of crude product. The crude product is under pressure 3 ¡Á 10-3Pa,Sublimation at a temperature of 225 C gave compound [69] (light yellow solid)., 351498-10-7
351498-10-7 6,6′-((1E,1’E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2,4-di-tert-butylphenol) 135404188, achiral-catalyst compound, is more and more widely used in various fields.
Reference£º
Patent; TORAY ADVANCED MATERIALS RESEARCH LABORATORIES (CHINA) CO., LTD.; WAN, PENG; JIN, GUANGNAN; IKEDA, TAKESHI; LI, JINCAI; TANAKA, DAISAKU; (48 pag.)TW2019/25212; (2019); A;,
Chiral Catalysts
Chiral catalysts – SlideShare